Skip to main content

Month: January 2024

Danny Robinson Named CEO of The Martin Agency

Martin CCO Danny Robinson to lead award-winning agency into the next chapter New York, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) announced today that Danny Robinson has been named CEO of The Martin Agency. He’ll be taking on the leadership responsibilities from Kristen Cavallo, who has led The Martin Agency for the past six years and was named Global CEO of sister agency MullenLowe Group fourteen months ago. An industry veteran, Robinson has been with The Martin Agency for nearly two decades, serving most recently as its Chief Creative Officer. During his time at Martin, Robinson has helped lead the agency in its mission to fight against invisibility, infusing that idea throughout the creative output. Since being named CCO in 2020, Robinson has overseen some of Martin’s most recognizable work, including...

Continue reading

Atari completes investment in tinyBuild

Atari completes investment in tinyBuild Paris, France (January 30, 2024 – 6.00 pm CET) – Atari® — one of the world’s most iconic consumer brands and interactive entertainment producers — today announces the completion of its US$2 million investment in tinyBuild, Inc, (“tinyBuild”) announced on December 21, 2023, as part of tinyBuild’s announced capital increase. tinyBuild (AIM: TBLD) has completed a US$12 million capital increase by means of the issue of new common shares. Upon completion and based on the results of the subscription, Atari holds 7.9% of tinyBuild share capital. Atari and Irata LLC, a holding company controlled by Wade Rosen, Chairman and CEO of Atari, have agreed that Irata will provide financing to Atari in the form of a new shareholder loan, for the payment of this investment, or US$2 million. About...

Continue reading

Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery’ Canine Respiratory Illness

Leveraging its database of over three million pets, Trupanion builds on its series to unveil latest canine respiratory health trends with global veterinary authorities SEATTLE, Jan. 30, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, is reconvening world-renowned animal health and infectious disease experts in an upcoming live event. The session will provide the latest insights into the current state of canine respiratory illness in North America, and follows the exceptional interest generated by their November 2023 event. During the free, live webcast, Trupanion will share data from their extensive database spanning over three million pets to identify North American and regional trends, pinpoint hot spots, and highlight recent activity. Additionally, the panel...

Continue reading

GROUPE PARTOUCHE: Annual Income 2022/2023 – Income driven by the strong growth in the activity

Annual Income 2022/2023 Income driven by the strong growth in the activity        Turnover:                                        € 423.8 M (+9.0%) EBITDA:                                          € 76.1 M (+0.7%) Current operation income:             € 27.4 M (+18.3%) Net income:                                    € 23.4 M1 Solid financial situation                  Gearing of 0.1x and leverage of 0.8xContinuation of the investment programme and confidence in the prospectsParis, 30th January 2024, 06:00 p.m. During its meeting held on the 30th January 2024 and after having reviewed the management report of Groupe Partouche Executive Board, the Supervisory Board examined the annual accounts at 31st October 2023, that are being audited. Strong growth in the annual turnover The Gross Gaming Revenue (GGR) records a strong growth...

Continue reading

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic opportunities THE WOODLANDS, TX, Jan. 30, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it has regained exclusive worldwide rights to its technology for cardiology field use from Impulse Medical, Inc. In December 2021, Autonomix granted Impulse Medical, Inc., a license to its technology for use in the field of cardiology. In July 2023, the Company entered into a termination agreement for the license agreement in exchange for the issuance, upon...

Continue reading

Believe acquires Punjabi powerhouse White Hill Music catalog, further reinforcing its leadership position in India

Believe acquires Punjabi powerhouse White Hill Music catalog, further reinforcing its leadership position in India Paris, January 30, 2023 – Believe, one of the world’s leading digital music companies, announces today the acquisition of White Hill Music’s premium Punjabi music catalog, confirming the strength of its partnership-based approach to local label and artists development, and its position as the best strategic partner for growing local labels. This acquisition is the result of a long-term partnership between Believe and White Hill Music (WHM), one of India’s most established music and film production studios. Since 2017, Believe has been a key driver of the digitalization of WHM’s catalog by supporting the growth of its roster across digital platforms. Believe has also signed multiple artists, who have some...

Continue reading

Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP

FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUPContinued total year growth in core business revenues, up 39% Successful deployment of the Group’s strategy:Proprietary products up at 30% of revenues Internationalization, with 38% of revenues now generated outside of FranceAcquisition of DID in Italy effective as of July 1st, 2023 Acquisition of Alpha Biotech, GenDx distributor, effective as of January 3rd, 2024Paris, January 30, 2024 – 5:45 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, today presents its consolidated annual revenues for the period ending December 31, 2023. Strong growth of core business at +39% Eurobio Scientific recorded revenues of €130.1 million for its core business at the end of 2023. Activities...

Continue reading

Interactive Whiteboard Market Set to Soar Past USD 4.88 Billion by 2030 | Skyquest Technology

Exploring the interactive whiteboard market reveals a diverse landscape characterized by technologies such as Resistive Membrane, Electromagnetic, Infrared, and Capacitive. These technologies enable touch-based, pen-based, and touchless interactions, catering to a range of end-users including the education sector (spanning K-12 and higher education), the corporate sector, and government and public institutions. This dynamic market presents opportunities for innovation and growth. Westford, USA, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global Interactive Whiteboard Market size is expected to reach USD 4.88 billion by 2030 and exhibit a CAGR of 12.51% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing adoption of technology in education and corporate sectors, the need for interactive...

Continue reading

RCP Advisors Announces Promotions

CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Following a successful year in 2023, RCP Advisors (“RCP”) is pleased to announce the promotion of Patrick dePenaloza to Principal, alongside several additional promotions across the firm. Patrick joined RCP’s business development team in 2016 following his earlier relevant experience at Neuberger Berman. Patrick oversees RCP’s fundraising efforts, in addition to providing support to the firm’s investment opportunities sourcing activities. Additionally, we are pleased to announce several other promotions across the firm: Andrew Dreyfuss, responsible for all tax matters related to the various RCP Funds, has been promoted to Manager; Kaitlyn Barcal, responsible for supporting the Compliance and Fund Administration teams as well as supporting limited partner communication and reporting and...

Continue reading

Intelligent Product Solutions Names Jan Niewiadomski to CTO

Product design firm expands management team with promotion of James Wightman to VP of Engineering and Ralph Cassara to Fellow and Digital Health Leader HAUPPAUGE, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) — Intelligent Product Solutions (IPS), an award-winning global product design firm, today announced that Jan Niewiadomski was named Chief Technology Officer. Expanding its management team, IPS also announced that James Wightman was promoted to Vice President of Engineering and Ralph Cassara to Fellow and Digital Health Leader. IPS is a subsidiary of Forward Industries (FORD). With deep experience in medical devices, defense, and international business, Jan Niewiadomski was promoted to Chief Technology Officer. During his more than eight years at IPS, he and the Systems Architecture team have been instrumental in architecting and developing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.